APA (7th ed.) Citation

A, G. G., M, F. A., G, V. P., A, G. T., R, C., D, C. L., . . . VJ, S. L. (2025). Targeting ELOVL6 to disrupt c-MYC driven lipid metabolism in pancreatic cancer enhances chemosensitivity. Nature communications, 16(1), 1694. https://doi.org/10.1038/s41467-025-56894-8

Chicago Style (17th ed.) Citation

A, García García, et al. "Targeting ELOVL6 to Disrupt C-MYC Driven Lipid Metabolism in Pancreatic Cancer Enhances Chemosensitivity." Nature Communications 16, no. 1 (2025): 1694. https://doi.org/10.1038/s41467-025-56894-8.

MLA (9th ed.) Citation

A, García García, et al. "Targeting ELOVL6 to Disrupt C-MYC Driven Lipid Metabolism in Pancreatic Cancer Enhances Chemosensitivity." Nature Communications, vol. 16, no. 1, 2025, p. 1694, https://doi.org/10.1038/s41467-025-56894-8.